Barbara A. Cornblatt, PhD, M.B.A. is a Professor of Psychiatry at the Albert Einstein College of Medicine, and is the Director of the Recognition and Prevention (RAP) program at the Zucker Hillside Hospital in New York.

For over 20 years, she has focused on research concerned with the causes and treatment of schizophrenia and other psychotic disorders. Her early research involved adolescents at genetic high-risk for schizophrenia and affective disorders, conducted first while at Columbia University College of Physicians and Surgeons and later at Mount Sinai School of Medicine.

More recently, Dr. Cornblatt has focused on the prevention of schizophrenia and other psychotic disorders. She launched the RAP program in 1997, which is concerned with the development and treatment of adolescents in the prodromal stages of illness, with close to 200 youngsters participating thus far.

Dr. Cornblatt has spoken at numerous national and international conferences. She has received research funding from the National Institute of Mental Health in the United States and from private foundations and industry. She has also received a number of awards in recognition of her research accomplishments. She has frequently served on funding committees, advisory boards and on the board of directors of scientific societies. She founded and is co-director of the International Prodromal Research Network, which sponsors international collaborations and annual workshops concerned with prodromal research methodology. Dr. Cornblatt is an author of over 150 scientific articles and book chapters.